Clinical Study Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson’s Disease
نویسندگان
چکیده
1Parkinson’s Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Cĺınic, University of Barcelona, Barcelona, Catalonia, Spain 2Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Catalonia, Spain 3Epilepsy Unit, Department of Neurology, Hospital Cĺınic, Barcelona, Catalonia, Spain 4Neurology Service, Cĺınica Dexeus, Barcelona, Catalonia, Spain 5Neurology Service, Hospital de Terrassa, Barcelona, Catalonia, Spain 6Cap Cl̀ınic de Neurologı̀a, Hospital Universitario Reus and Department of Medicine and Surgery, Universitat de Tarragona, Tarragona, Catalonia, Spain 7Neurology Service, Parc Sanitari Sant Joan de Déu, Sant Boi, Barcelona, Catalonia, Spain 8Neurology Service, Hospital Parc Tauĺı de Sabadell, Catalonia, Spain 9Cĺınica Juaneda, Palma de Mallorca, Balearic Islands, Spain
منابع مشابه
Night-time use of rotigotine in advanced Parkinson's disease.
Transdermal rotigotine was used in six patients with advanced Parkinson's disease and sleep disorders (UPDRS part II item 12 score ≥ 2) receiving oral levodopa and diurnal apomorphine infusions. Transdermal rotigotine (2-4 mg/24h) was used at night for four months. Sleep disorders improved, the total Parkinson's Disease Sleep Scale score falling by an average of 45%; significant improvements em...
متن کاملTransdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
Sleep disturbances occur frequently in patients with Parkinson's disease (PD). The aim of this study was to investigate the effects of rotigotine on sleep fluctuations in a sample of PD patients with self-reported complaints of nocturnal awakenings. This prospective, open-label, observational, and multicenter study enrolled consecutive outpatients with PD and administered rotigotine (mean dose ...
متن کاملThe Effects of Bilateral Subthalamic Nucleus Stimulation on Cognitive and Neuropsychiatric Functions in Parkinson’s Disease: A Case-Control Study
Introduction: Parkinson’s disease is one of the most disabling diseases which by electrode implantation and stimulation of subthalamic nucleus (STN), much progress has been made in the treatment of drug resistant patient. This new method of neurosurgery may have some neuropsychological side effects on the patients. The main aim of this study is to evaluate the effects of this kind of treatment ...
متن کاملUpdate to the AASM Clinical Practice Guideline: "The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses".
1037 Letter to the Editor—Aurora et al In January 2012, the AASM Board of Directors approved the Standards of Practice paper titled “The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses.” The 2012 update included a new drug not reviewed in the previous 2004 AASM gu...
متن کاملRotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.
The main clinical features of Parkinson’s disease are tremor, muscular rigidity, akinesia (inability to move), and postural instability. Other features of the disease include changes in gait, mask-like face, micrographia (progressively smaller handwriting), and psychiatric symptoms; depression occurs in 50% of patients over the course of their illness. The diagnosis is made by clinical symptoms...
متن کامل